https://www.selleckchem.com/products/ly333531.html
vious validation studies for their own study purposes. About 70% of women with breast cancer survive at least 10 years after diagnosis. We constructed an algorithm to ascertain late breast cancer recurrence-which we define as breast cancer that recurs 10 years or more after primary diagnosis (excluding contralateral breast cancers)-using Danish nationwide medical registries. We used clinical information recorded in medical records as a reference standard. Using the Danish Breast Cancer Group clinical database, we ascertained data on 21
Like
Comment
Share
